CV Sciences, Inc. Income Statement
CVSI|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$14M
FY2025
Gross Profit
$7M
49.0% gross margin
Operating Income
-$470,000
FY2025
Net Income
-$958,000
FY2025
CV Sciences, Inc. reported $14M in revenue and $958,000 in net loss for FY2025. Revenue has grown at a 16.7% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -8.81 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -65.3% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.8M | $15.7M | $16.0M | $16.2M | $20.0M | $24.4M | $53.7M | $48.2M | $20.7M | $11.1M | $11.5M | $10.2M | $2.2M |
| Cost of Revenue | $7.0M | $8.5M | $8.9M | $10.7M | $11.4M | $13.4M | $18.6M | $14.4M | $6.2M | $4.1M | $4.8M | $4.4M | $880.5K |
| Gross Profit | $6.8M | $7.2M | $7.1M | $5.5M | $8.6M | $11.0M | $35.1M | $33.9M | $14.5M | $7.0M | $6.7M | $5.8M | $1.3M |
| SG&A Expense | $7.6M | $9.2M | $9.7M | $12.1M | $25.9M | $30.7M | $46.5M | $21.7M | $16.2M | $13.1M | $17.4M | $13.4M | $2.4M |
| R&D Expense | $122.0K | $118.0K | $151.0K | $307.0K | $1.2M | $2.9M | $5.9M | $1.9M | $724.0K | $1.2M | $1.3M | $999.3K | $524.5K |
| Operating Income | -$470.0K | -$2.2M | $3.4M | -$6.8M | -$18.4M | -$22.6M | -$17.2M | $10.2M | -$4.9M | -$13.1M | -$11.2M | -$8.6M | -$1.6M |
| Interest Expense | - | - | - | $600.0K | $38.0K | - | - | $153.0K | $507.0K | $1.1M | $968.6K | $615.3K | $372.1K |
| Income Tax | $9.0K | -$8.0K | -$6.0K | -$47.0K | -$87.0K | -$317.0K | -$615.0K | $93.0K | -$482.0K | $0 | $0 | $0 | $0 |
| Net Income | -$958.0K | -$2.4M | $3.1M | -$8.2M | -$15.6M | -$22.3M | -$16.6M | $10.0M | -$4.9M | -$14.1M | -$12.2M | -$1.3M | -$2.3M |
| EPS (Basic) | -$0.01 | $0.02 | -$0.07 | -$0.14 | -$0.22 | - | $0.11 | -$0.06 | - | - | -$0.04 | -$0.23 | - |
| EPS (Diluted) | -$0.01 | $0.02 | -$0.07 | -$0.14 | -$0.22 | -$0.17 | $0.09 | -$0.06 | -$0.27 | -$0.35 | - | - | -$0.01 |
| Shares Outstanding | 184.3M | 161.7M | 152.1M | 112.5M | 100.7M | 99.4M | 94.9M | 90.5M | 57.6M | 45.5M | 33.4M | 15.6M | 7.0M |
| Gross Margin | 49.0% | 45.6% | 44.3% | 34.3% | 43.0% | 45.1% | 65.3% | 70.2% | 70.1% | 63.3% | 58.4% | 57.0% | 59.1% |
| Operating Margin | -3.4% | -13.9% | 21.0% | -42.3% | -92.0% | -92.5% | -32.1% | 21.2% | -23.5% | -118.2% | -97.2% | -83.9% | -75.1% |
| Profit Margin | -7.0% | -15.2% | 19.4% | -50.7% | -77.6% | -91.2% | -30.9% | 20.7% | -23.7% | -127.8% | -106.1% | -12.9% | -106.8% |